These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 37262366

  • 1. Intraorbital lymphatic-venous malformation in an adult patient: is sirolimus the key?
    Ruiz Velasco Santacruz A, Nieva Pascual I, Cifuentes Canorea P, Díaz Ramírez S, Pascual González M.
    Orbit; 2024 Aug; 43(4):535-538. PubMed ID: 37262366
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
    Le Sage S, David M, Dubois J, Powell J, McCuaig CC, Théorêt Y, Kleiber N.
    Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
    [Abstract] [Full Text] [Related]

  • 3. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
    Shoji MK, Shishido S, Freitag SK.
    Ophthalmic Plast Reconstr Surg; 2020 Jul; 36(3):215-221. PubMed ID: 31990892
    [Abstract] [Full Text] [Related]

  • 4. Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone.
    Kim D, Benjamin L, Wysong A, Hovsepian D, Teng J.
    Dermatol Ther; 2015 Jul; 28(4):218-21. PubMed ID: 25753853
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oral rapamycin: an alternative in children with complicated vascular abnormalities.
    Gómez Sánchez A, Redondo Sedano JV, Pérez Alonso V, Martí Carrera ME, Baro Fernández M, Palencia Pérez SI, Gallego Herrero MC, Gómez Fraile A, Delgado Muñoz MD.
    Cir Pediatr; 2020 Oct 01; 33(4):183-187. PubMed ID: 33016658
    [Abstract] [Full Text] [Related]

  • 7. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
    Maruani A, Tavernier E, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, Guibaud L, Vabres P, Carmignac V, Mallet S, Barbarot S, Chiaverini C, Droitcourt C, Bursztejn AC, Lengellé C, Woillard JB, Herbreteau D, Le Touze A, Joly A, Léauté-Labrèze C, Powell J, Bourgoin H, Gissot V, Giraudeau B, Morel B.
    JAMA Dermatol; 2021 Nov 01; 157(11):1289-1298. PubMed ID: 34524406
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of sirolimus in children with lymphatic malformations of the head and neck.
    Wiegand S, Dietz A, Wichmann G.
    Eur Arch Otorhinolaryngol; 2022 Aug 01; 279(8):3801-3810. PubMed ID: 35526176
    [Abstract] [Full Text] [Related]

  • 10. Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review.
    Saibene AM, Rosso C, Felisati G, Pignataro L, Schindler A, Ghilardi G, Colletti G, Gaffuri M, Mozzanica F.
    Eur Arch Otorhinolaryngol; 2023 Aug 01; 280(8):3529-3540. PubMed ID: 37115326
    [Abstract] [Full Text] [Related]

  • 11. Sirolimus for the Treatment of a Massive Capillary-Lymphatico-Venous Malformation: A Case Report.
    Vlahovic AM, Vlahovic NS, Haxhija EQ.
    Pediatrics; 2015 Aug 01; 136(2):e513-6. PubMed ID: 26148957
    [Abstract] [Full Text] [Related]

  • 12. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
    Dodds M, Tollefson M, Castelo-Soccio L, Garzon MC, Hogeling M, Hook K, Boull C, Maguiness S.
    Pediatr Dermatol; 2020 Mar 01; 37(2):272-277. PubMed ID: 31957126
    [Abstract] [Full Text] [Related]

  • 13. Topical rapamycin and microcystic lymphatic malformations.
    Gu Y, Sebaratnam DF.
    J Am Acad Dermatol; 2024 Jan 01; 90(1):e29-e30. PubMed ID: 37717734
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M, Nozawa A, Yasue S, Endo S, Asada R, Hashimoto H, Fukao T.
    Orphanet J Rare Dis; 2019 Jun 13; 14(1):141. PubMed ID: 31196128
    [Abstract] [Full Text] [Related]

  • 17. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P, Dore M, Cerezo VN, Cervantes M, Sánchez AV, Ferrero MM, González MD, Lopez-Gutierrez JC.
    Eur J Pediatr Surg; 2017 Feb 13; 27(1):86-90. PubMed ID: 27723921
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.
    Badia P, Ricci K, Gurria JP, Dasgupta R, Patel M, Hammill A.
    Pediatr Blood Cancer; 2020 Apr 13; 67(4):e28088. PubMed ID: 31930696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.